Literature DB >> 26099055

Assessment of Bulbar Redness with a Newly Developed Keratograph.

Suqian Wu1, Jiaxu Hong, Lijia Tian, Xinhan Cui, Xinghuai Sun, Jianjiang Xu.   

Abstract

PURPOSE: To determine the validity and reliability of the clinical assessment of bulbar redness (BR) using a newly developed corneal topographer.
METHODS: This is a cross-sectional diagnostic evaluation study. The BR scores [Oculus Index (OI)] from 30 eyes of 26 patients with different degrees of conjunctival hyperemia were assessed and scored automatically using a new method: a keratograph equipped with scanning and scoring software. The values obtained via this system were correlated with three image-based comparative subjective scales: the Institute for Eye Research (IER), the Efron, and the Validated Bulbar Redness (VBR) grading scales. The IER and Efron scores were interpolated to 0.1 unit, and the VBR scores were interpolated to 1 unit. We also evaluated the repeatability of each method and the level of agreement between the OI score and the scores achieved using the three other image-based methods.
RESULTS: There was a significant correlation between the OI score and the scores obtained with the IER (r = 0.921, p < 0.001), Efron (r = 0.958, p < 0.001), and VBR (r = 0.965, p < 0.001) scales. The intraobserver intraclass correlation coefficients were 0.947, 0.874, 0.810, and 0.920 for the OI, IER, Efron, and VBR, respectively, and the intraobserver coefficients of repeatability were 13.924, 16.111, 17.684, and 16.900, respectively. Furthermore, the interobserver intraclass correlation coefficients were 0.889, 0.880, 0.884, and 0.881 for the OI, IER, Efron, and VBR, respectively, and the interobserver coefficients of repeatability were 15.934, 16.366, 22.059, and 21.373, respectively.
CONCLUSIONS: The OI is an objective and reliable method for scoring BR. Its reproducibility was the highest of all the four modalities. The keratograph is recommended, therefore, as a suitable alternative for BR assessment.

Entities:  

Mesh:

Year:  2015        PMID: 26099055     DOI: 10.1097/OPX.0000000000000643

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  15 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

2.  A new scale for the assessment of conjunctival bulbar redness.

Authors:  Ilaria Macchi; Vatinee Y Bunya; Mina Massaro-Giordano; Richard A Stone; Maureen G Maguire; Yuanjie Zheng; Min Chen; James Gee; Eli Smith; Ebenezer Daniel
Journal:  Ocul Surf       Date:  2018-06-06       Impact factor: 5.033

3.  Autologous Platelet-Rich Plasma Drops for Evaporative Dry Eye Disease from Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Fahmeeda Murtaza; Dana Toameh; Hannah H Chiu; Eric S Tam; Sohel Somani
Journal:  Clin Ophthalmol       Date:  2022-07-06

Review 4.  Ocular redness - I: Etiology, pathogenesis, and assessment of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Sonia Anchouche; Ann Yung; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-16       Impact factor: 6.268

5.  Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study.

Authors:  Chien-Chia Su; Yi-Chieh Lee; Peter Richmond Candano Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-12       Impact factor: 3.535

Review 6.  The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research.

Authors:  Neeta S Roy; Yi Wei; Eric Kuklinski; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

7.  Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use.

Authors:  Pedro Molina-Solana; Francisco de Borja Domínguez-Serrano; Antonio Manuel Garrido-Hermosilla; Jesús Montero-Iruzubieta; Ana Fernández-Palacín; Enrique Rodríguez-de-la-Rúa-Franch; Manuel Caro-Magdaleno
Journal:  Clin Ophthalmol       Date:  2020-04-28

8.  Awareness of treatment: A source of bias in subjective grading of ocular complications.

Authors:  Genis Cardona; Noelia Esterich
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

9.  Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?

Authors:  Ming-Tse Kuo; Po-Chiung Fang; Shu-Fang Kuo; Alexander Chen; Yu-Ting Huang
Journal:  Int J Mol Sci       Date:  2021-01-03       Impact factor: 5.923

10.  Short-term effect of a developed warming moist chamber goggle for video display terminal-associated dry eye.

Authors:  Yueping Ren; Jie Chen; Qinxiang Zheng; Wei Chen
Journal:  BMC Ophthalmol       Date:  2018-02-07       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.